ArticleMedicine2026
Identification of senescence-related biomarker for aortic dissection based on bioinformatics and machine learning algorithms.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aortic dissection (AD) is a vascular surgical disease that seriously threatens human health. Due to a high misdiagnosis rate and unclear pathogenesis, it brings greater challenges to AD patients and vascular surgeons. This study aimed to explore sensitive diagnostic markers and potential therapeutic targets of AD from the perspective of cellular senescence, which has been our long-term concern. We downloaded the expression matrix of AD and control samples from the Gene Expression Omnibus database and obtained the senescence-related gene set. Differentially expressed genes (DEGs) in AD and control groups were analyzed by the "limma" package. Gene Ontology, Disease Ontology, and Kyoto Encyclopedia of Genes and Genomes enrichment analyses were carried out to demonstrate the enrichment function of DEGs. Two sensitive screening diagnostic marker algorithms, the least absolute shrinkage and selection operator and support vector machine-recursive feature elimination, were used to identify target genes in combination with senescence-related genes. Receiver operating characteristic curves for targeted genes were plotted to assess diagnostic efficacy. Gene set enrichment analysis was performed to preliminarily explore the pathways enriched in the 2 groups. CIBERSORT was used to look for differentially infiltrating immune cells, and Spearman analysis was carried out to explore the association between targeted genes and infiltrating immune cells. A total of 111 DEGs were identified, which were closely related to regulation of leukocyte migration, cellular transition metal ion homeostasis, transition metal ion homeostasis, and detoxification of copper ion from Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analysis. Disease Ontology analysis found that these DEGs were mainly involved in acute myocardial infarction, vasculitis, and coronary artery disease. Hexokinase-3 (HK3) was identified as an overlapping gene of least absolute shrinkage and selection operator, support vector machine-recursive feature elimination, and senescence. HK3 showed good diagnostic efficacy (area under the receiver operating characteristic curve = 0.924 in the integrated cohort and 0.914 in the validation cohort). Correlation analysis results showed that HK3 was positively correlated with monocytes, neutrophils, and natural killer cells resting, while B cells naive, mast cells resting, and macrophages M1 were negatively correlated. HK3 was a potential biomarker for AD diagnosis and a target for precision therapy, and HK3 is also closely related to immune infiltration.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.